Healthcare -
Biotechnology - NASDAQ - US
$ 2.28
-3.8 %
$ 60.5 M
Market Cap
-2.13
P/E
GANX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities GANX - Gain Therapeutics, Inc.
12.6 M
LAST VALUE
-44.98%
2 YEAR CAGR
66.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR